Interesting Image

Striking Visualization of Diffuse Congenital Nesidioblastosis on Ga-68 DOTATATE PET/CT

10.4274/mirt.galenos.2018.38039

  • Fevziye Canbaz
  • Murat Aydın
  • Bilge Can Meydan
  • Meltem Ceyhan Bilgici
  • Ender Arıtürk

Received Date: 22.09.2018 Accepted Date: 04.11.2018 Mol Imaging Radionucl Ther 2019;28(2):83-85

“Nesidioblastosis”, later renamed as “persistent hyperinsulinemic hypoglycemia of infancy” presents as either focal or diffuse neo-differentiation of pancreatic Langerhans islet cells from the ductal epithelium. Differentiation of focal disease from diffuse involvement is crucial for optimal disease management. The current methods used to differentiate the two forms pre-operatively are invasive techniques. The definite role of imaging modalities to differentiate diffuse versus focal form has not yet been proven. Herein, we report a 15 day-old infant having diffuse nesidioblastosis, successfully demonstrated by Ga-68 DOTATATE positron emission tomography/computed tomography imaging that was histopathologically confirmed.

Keywords: Nesidioblastosis, hyperinsulinemic hypoglycemia, differential diagnosis, Ga-68 DOTATATE PET/CT

Ethics

Informed Consent:Consent form was filled out by all participants.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: E.A., H.M.A., Concept: F.C., Design: F.C., Data Collection or Processing: F.C., Analysis or Interpretation: F.C., B.C.M., M.C.B., Literature Search: F.C., Writing: F.C.

Conflict of Interest:No conflict of interest was declared by the authors.

Financial Disclosure:The authors declared that this study received no financial support.

Images

  1. Dutta S, Venkataseshan S, Bal C, Rao KL, Gupta K, Bhattacharya A, Narang A. Novel use of somatostatin receptor scintigraphy in localization of focal congenital hyperinsulinism: Promising but fallible. J Pediatr Endocrinol Metab 2009;22:965-969.
  2. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Dionisi Vici C, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fékété C, Robert JJ, Saudubray JM. Clinical Features of 52 Neonates with Hyperinsulinism. N Engl J Med 1999;340:1169-1175.
  3. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dollé F, Nihoul-Fékété C, Syrota A, Brunelle F. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005;46:560-566.
  4. Brunelle F, Negre V, Barth MO, Fekete CN, Czernichow P, Saudubray JM, Kuntz F, Tach T, Lallemand D. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19:100-103.
  5. Dubois J, Brunelle F, Touati G, Sebag G, Nuttin C, Thach T, Nikoul-Fekete C, Rahier J, Saudubray JM. Hyperinsulinism in children: Diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512-516.
  6. Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2000;82:108-112.
  7. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H, Ganguly A, Freifelder R, Adzick NS, Alavi A, Stanley CA. Diagnosis and Localization of Focal Congenital Hyperinsulinism by 18F-Fluorodopa PET Scan. J Pediatr 2007;150:140-145.
  8. Arun S, Rai Mittal B, Shukla J, Bhattacharya A, Kumar P. Diffuse nesidioblastosis diagnosed on a Ga-68 DOTATATE positron emission tomography/computerized tomography. Indian J Nucl Med 2013;28:163-164